Omeros reported $52.84M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 10.46M 805K
Adamas Pharmaceuticals ADMS:US 31.13M 2.29M
Adma Biologics ADMA:US $ 33.41M 2.2M
Aerie Pharmaceuticals AERI:US $ 58.69M 1.5M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 366.71M 2.89M
Biomarin Pharmaceutical BMRN:US $ 490.02M 29.08M
Cytokinetics CYTK:US $ 57.64M 10.48M
Dynavax Technologies DVAX:US $ 48.83M 5.98M
Gilead Sciences GILD:US $ 3971M 438M
Heron Therapeutics HRTX:US $ 82.91M 10.78M
Insmed INSM:US $ 151.62M 27.57M
Intercept Pharmaceuticals ICPT:US $ 95.82M 15.19M
Knight Therapeutics Inc GUD:CN C$ 65.6M 17.23M
Macrogenics MGNX:US $ 71.04M 2.86M
Mirati Therapeutics MRTX:US $ 164.19M 31.76M
Omeros OMER:US $ 52.84M 1.17M
Pacira Pharmaceuticals PCRX:US $ 100.75M 1.16M
Pfizer PFE:US $ 13063M 3998M
Regulus Therapeutics RGLS:US $ 6.64M 840K
Rockwell Medical RMTI:US $ 22.96M 305K
Sangamo Biosciences SGMO:US $ 76.57M 3.99M
Sarepta Therapeutics SRPT:US $ 331.66M 32.87M
United Therapeutics UTHR:US $ 226.6M 217.3M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M
Vital Therapies VTL:US $ 19.17M 13.22M
Xoma XOMA:US $ 4.26M 2.54M